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Hypochlorous acid (HOCl) is the most powerful oxidant produced by human neutrophils and contributes to the damage caused
by these inﬂammatory cells. It is produced from H2O2 and chloride by the heme enzyme myeloperoxidase (MPO). Based on ﬁndings
that betalains provide antioxidant and anti-inﬂammatory eﬀects, we performed the present kinetic study on the interaction between
the betalains, betanin and indicaxanthin, with the redox intermediates, compound I and compound II of MPO, and its major cyto-
toxic product HOCl. It is shown that both betalains are good peroxidase substrates for MPO and function as one-electron reduc-
tants of its redox intermediates, compound I and compound II. Compound I is reduced to compound II with a second-order rate
constant of (1.5 ± 0.1) · 106 M1 s1 (betanin) and (1.1 ± 0.2) · 106 M1 s1 (indicaxanthin), respectively, at pH 7.0 and 25 C.
Formation of ferric (native) MPO from compound II occurs with a second-order rate constant of (1.1 ± 0.1) · 105 M1 s1 (betanin)
and (2.9 ± 0.1) 105 M1 s1 (indicaxanthin), respectively. In addition, both betalains can eﬀectively scavenge hypochlorous acid with
determined rates of (1.8 ± 0.2) · 104 M1 s1 (betanin) and (7.7 ± 0.1) · 104 M1 s1 (indicaxanthin) at pH 7.0 and 25 C. At neu-
tral pH and depending on their concentration, both betalains can exhibit a stimulating and inhibitory eﬀect on the chlorination
activity of MPO, whereas at pH 5.0 only inhibitory eﬀects were observed even at micromolar concentrations. These ﬁndings are
discussed with respect to our knowledge of the enzymatic mechanisms of MPO.
 2005 Elsevier Inc. All rights reserved.
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ease, asthma, rheumatoid arthritis, and inﬂammatory
bowel diseases, are the major cause of morbidity and
mortality in the western world, and involve inappropri-
ate and undesirable activation of the immune system,
which causes tissue damage and pathology. Especially
the human heme enzyme myeloperoxidase (MPO) is
known to be involved in oxygen-dependent antimicro-
bial action and is dominant in phagocytic neutrophils0006-291X/$ - see front matter  2005 Elsevier Inc. All rights reserved.
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ﬂict tissue damage through its ability to catalyse the pro-
duction of a complex array of reactive oxidants
including hypohalous acids (e.g., hypochlorous acid/hy-
pochlorite), nitrogen dioxide, organic free radicals, and
numerous drug metabolites [2].
In the latest years, dietary phytochemicals have at-
tracted much attention for their beneﬁts on human
health. Flavonoids, for example, are probably the most
studied and well-known natural substances present in
plant foods that could provide antioxidant and anti-in-
ﬂammatory eﬀects [3]. Betalains are a class of cationized
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the yellow betaxanthins to the violet-red betacyanins
[4–6]. Betaxanthins are conjugates of betalamic acid
with amino acids or the corresponding amines (includ-
ing dopamine), while almost all betacyanins are deriva-
tives of betanidin, the conjugate of betalamic acid with
cyclo-Dopa. The hydroxyl groups at the C5 and C6 po-
sition of cyclo-Dopa can be either esteriﬁed or not with
carbohydrate derivatives to form various betacyanins
(Fig. 1A). Two betalains have been recently investi-
gated, the betacyanin betanin (5-O-glucose betanidine)
and the betaxanthin indicaxanthin, the adduct of beta-
lamic acid with proline [7–12] (Fig. 1B). Due to their re-
dox potentials [7], both molecules possess reducing
properties, and are able to increase the resistance of hu-
man LDL to oxidation acting as lipoperoxyl radical
scavengers [13]. Furthermore, betalains have been
shown to protect vascular endothelium cells, which are
a direct target of oxidative stress in inﬂammation, from
cytokine-induced redox state alteration [14].
Based on the reports about the redox properties and
antioxidative activities of these betalains as well as on
the fact that class III-type plant peroxidases have been
shown to be able to oxidize betanidin and betanin [15],
we performed this study about the interaction of betanin
and indicaxanthin with human myeloperoxidase and its
major reaction product hypochlorous acid (HOCl).
MPO can catalyse both two- and one-electron oxidation
reactions. In the halogenation cycle, compound I, which
is formed upon oxidation of ferric MPO by hydrogen
peroxide (Reaction 1), is known to oxidize (pseudo-)ha-
lides (i.e., chloride, bromide, thiocyanate; X) via a sin-Fig. 1. Chemical structure of betalains.gle two-electron reaction to produce the respective
cytotoxic hypohalous acids (XOH) and regenerate the
native enzyme (Reaction 2).
ferric MPO þH2O2 ¡ compound IþH2O
ðReaction 1Þ
compound IþX ¡ ferric MPOþXOH
ðReaction 2Þ
In the peroxidase cycle, compound I is reduced via com-
pound II to the native enzyme (Reactions 3 and 4) there-
by catalysing one-electron oxidation reactions of
electron donors (AH2) and releasing the respective rad-
icals (AH).
compound IþAH2 ¡ compound IIþAH
ðReaction 3Þ
compound IIþAH2 ¡ ferric MPOþAH þH2O
ðReaction 4Þ
In principle, reducing compounds such as betalains
could interfere with all steps in the catalytic cycle of
MPO (Reactions 1–4), as well as with its major reaction
product HOCl (Reaction 2). Here, by using the sequen-
tial-mixing stopped-ﬂow technique, we investigated the
electron-donating capacity of betanin and indicaxanthin
with both compound I and compound II of MPO. In de-
tail, we present actual bimolecular rate constants of
Reactions 3 (k3) and 4 (k4) and demonstrate that low
micromolar betalain concentrations enhance the chlori-
nation activity of MPO at pH 7.0, whereas at higher
concentrations they inhibit the MPO-mediated chlorina-
tion reactions by scavenging of hypochlorous acid.Materials and methods
Highly puriﬁed myeloperoxidase of a purity index (A430/A280) of at
least 0.85 was purchased from Planta Naturstoﬀe Vertriebs GmbH
(http://www.myeloperoxidase.at). Its concentration was calculated
using e430 = 91 mM1 cm1 [16]. Hydrogen peroxide, obtained from a
30% solution, was diluted shortly before use and the concentration was
determined by absorbance measurement at 240 nm where the extinc-
tion coeﬃcient is 39.4 M1 cm1 [17]. All chemicals were purchased
from Sigma Chemical at the highest grade available.
Puriﬁcation of indicaxanthin and betanin. Betanin and indicaxan-
thin were separated from methanolic extracts of prickly pear fruits by
gel ﬁltration on a Sephadex G-25 column (40 · 2.2 cm) according to
Kanner et al. [18], with minor modiﬁcations. Brieﬂy, prickly pear
fruits, collected in September–November 2001 in Sicily (Italy), were
obtained from a local market, and were processed within 48–72 h from
collection (four diﬀerent lots of fruits, at comparable ripening stages,
were analysed for each cultivar). The fruits were peeled and ﬁnely
chopped. The pulp was separated from the seeds, weighted, and 100 g
pulp samples were homogenized with 100 mL methanol; aliquots from
2 g fresh pulp were eluted with 1% acetic acid and fractions (2.5 mL)
were collected, and tested spectrophotometrically at 482 and 536 nm
for the presence of indicaxanthin and betanin, respectively [9,10]. The
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a complete separation of the two pigments was achieved. The isolated
pigments were submitted to high performance liquid chromatography
analysis on a Varian Microsorb C-18 column (1 · 25 cm, Varian, Palo
Alto, CA, USA), eluted with a 20 min linear gradient elution from
solvent A (1% acetic acid in water) to 20% solvent B (1% acetic acid in
acetonitrile) with a ﬂow rate of 2 mL/min [10,19]. Spectrophotometric
revelation was at 536 and 482 nm for betanin (12.4 min) and indica-
xanthin (13.6 min), respectively. The elution volumes relevant to
indicaxanthin and betanin were collected. Samples after cryoessicca-
tion were resuspended for measurements in phosphate buﬀer at suit-
able concentrations. Concentrations were determined by using the
extinction coeﬃcients of e536 = 65,000 M
1 cm1 (betanin) and
e482 = 42,800 M
1 cm1 (indicaxanthin).
Stopped-ﬂow spectroscopy. The sequential stopped-ﬂow apparatus
(Model SX-18MV) and the associated computer system were from
Applied Photophysics (UK). For a total of 100 mL/shot into a ﬂow
cell with 1 cm light path, the fastest time for mixing two solutions and
recording the ﬁrst data point was ca. 1.5 ms. Because of the inherent
instability of MPO compound I [16], the sequential-ﬂow (multimixing)
technique had to be used for determination of rates of the reaction of
compound I with both betanin and indicaxanthin. The transition
of compound I to compound II was followed at the Soret maximum of
compound II (456 nm). In a typical experiment, MPO (4 lM heme) in
5 mM buﬀer (pH 7.0) was premixed with 40 lM H2O2 in distilled
water. After a delay time of 20 ms, compound I was allowed to react
with varying concentrations of betalains in 200 mM phosphate buﬀer
(pH 7.0). The pH after mixing was measured at the outlet.
Reduction of compound II by betalains was performed as de-
scribed recently [20]. In a typical experiment, MPO (4 lM heme) in
5 mM buﬀer (pH 7.0) was premixed with 40 lM H2O2 and 1.8 mM
homovanillic acid in distilled water. After a delay time of 40 s, com-
pound II was allowed to react with varying concentrations of betalains
in 200 mM phosphate buﬀer (pH 7.0). The reactions were followed at
456 nm (disappearance of compound II) and 430 nm (formation of
ferric MPO). Alternatively, compound II formation and reduction
could be followed in one measurement. The resulting biphasic curves at
456 nm showed the initial formation of compound II and then its
subsequent reaction with the betalains causing an exponential decrease
in absorbance at 456 nm.
At least three determinations (2000 data points) of kobs were per-
formed for each substrate concentration and the mean value was used
in a plot of kobs versus substrate concentration. The ﬁnal betalain
concentrations were at least 10 times in excess of the enzyme to assure
pseudo-ﬁrst-order kinetics. All reactions were performed at 25 C.
Reduction of both compound I and compound II was also studied by
using the the diode-array detector attached to the stopped-ﬂow
apparatus. Typically, the ﬁnal heme concentration used in these
experiments was 2 lM.
Myeloperoxidase-catalysed chlorination of monochlorodimedon.
Monochlorodimedon (MCD) is a substrate often used to study the
MPO-catalysed chlorination [21]. Chlorination of MCD to dichloro-
dimedon results in a decrease in absorbance at 290 nm. MCD
(100 lM) was dissolved in 100 mM phosphate/citrate buﬀer (pH 5.0)
or phosphate buﬀer (pH 7.0) containing 100 lM H2O2 and 100 mM
chloride in the presence or absence of betalains. Reactions were started
by addition of MPO (20 nM at pH 5.0 and 200 nM at pH 7.0) and
performed in a Beckman DU 640 spectrophotometer equipped with a
temperature controller at 25 C.
Polarographic measurements of H2O2 utilization. The enzymatic
activity of MPO was also determined by measuring the hydrogen
peroxide consumption in the presence of betalains polarographically
by using a platinum electrode covered with a hydrophilic membrane
and ﬁtted to an Amperometric Biosensor Detector 3001 (Universal
Sensors, USA). At pH 7.0, the applied electrode potential was 0.65 V.
The electrode ﬁlling solution was prepared freshly every day and the
H2O2 electrode was calibrated against known concentrations ofhydrogen peroxide. All reactions were performed in a thermally jacked
tube at 25 C and started by addition of 5–10 nM MPO to a 5 mL
solution containing 100 lM hydrogen peroxide in 100 mM phosphate
buﬀer, pH 7.0, and various betalain concentrations (25 C).Results and discussion
In the ﬁrst part of this study, the reactivity of betanin
and indicaxanthin (Fig. 1) with the redox intermediates,
compound I and compound II of human myeloperoxi-
dase, was investigated. The sequential-mixing stopped-
ﬂow technique had to be used because of the instability
of the redox intermediates of myeloperoxidase. The
Soret maximum of ferric MPO is at 430 nm and upon
addition of H2O2 (i.e., compound I formation) a hypo-
chromicity of about 50% is observed. In the presence of
one-electron donors, compound I is reduced to com-
pound II, which has its Soret band at 456 nm and an-
other maximum at 629 nm. A direct conversion of
compound I to compound II exhibits distinct isosbestic
points at 435, 489, 585, and 657 nm [20]. In our exper-
iments, both betalains were good peroxidase substrates
(see below) which allowed us to follow compound II
formation and reduction in one measurement at
456 nm (absorbance maximum of compound II). The
resulting biphasic curves at 456 nm showed the initial
formation of compound II (Figs. 2B and 3B) and then
its subsequent reduction by the betalains causing an
exponential decrease in absorbance at 456 nm (Figs.
2D and 3D).
Betalain-mediated compound I and compound II reduction
Compound II formation (k3) was followed at
456 nm (Fig. 2B). Both betanin and indicaxanthin were
eﬃcient in reduction of compound I (Figs. 2 and 3).
All reactions were monophasic and the time traces
could be ﬁtted to a single-exponential function (Figs.
2B and 3B). The obtained pseudo-ﬁrst-order rate con-
stants were linearly dependent on the concentration
of the electron donor and allowed calculation of the
second-order rate constants (k3) from the correspond-
ing plots (Figs. 2A and 3A). The corresponding bimo-
lecular rate constants for betanin and indicaxanthin
were calculated to be (1.5 ± 0.1) · 106 M1 s1 (beta-
nin) and (1.1 ± 0.2) · 106 M1 s1 (indicaxanthin) at
pH 7.0 and 25 C. Thus, betalain oxidation by com-
pound I is about 60 times faster than chloride oxida-
tion, which was determined to be 2.4 · 104 M1 s1 at
pH 7.0 [16]. Thus, both betalains are excellent compet-
itors of chloride for compound I reduction and in the
presence of both betalains and chloride it depends on
the actual concentrations whether MPO follows the
chlorination or the peroxidase cycle.
Similarly, compound II was reduced in a one-electron
process by betanin and indicaxanthin. Clear isosbestic
Fig. 2. Reaction of compound I and compound II of myeloperoxidase (MPO) with betanin. Experiments were carried out in the sequential-mixing
stopped-ﬂow mode. (A) Pseudo-ﬁrst-order rate constants, kobs, for compound I reduction plotted against betanin concentrations. (B) Time trace and
single-exponential ﬁt of the reaction between 1 lMMPO compound I and 20 lM betanin, followed at 456 nm (absorbance maximum of compound
II). Conditions: 100 mM phosphate buﬀer pH 7.0 and 25 C. (C) Pseudo-ﬁrst-order rate constants, kobs, for compound II reduction plotted against
betanin concentrations. (D) Time trace and single-exponential ﬁt of the reaction between 1 lM MPO compound II and 30 lM betanin, followed at
456 nm. Conditions as in (B).
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back to the ferric resting enzyme. The corresponding
time traces at 456 nm (disappearance of compound II)
or 430 nm (formation of ferric MPO; not shown) exhib-
ited a typical single-exponential behaviour (Figs. 2D and
3D) and yielded bimolecular rate constants (k4) for beta-
nin and indicaxanthin of (1.1 ± 0.1) · 105 M1 s1 and
(2.9 ± 0.1) · 105 M1 s1 at pH 7.0 and 25 C (Figs.
2C and 3C).
Both betalains are good substrates of MPO and dur-
ing their steady-state oxidation by the system MPO/
H2O2, compound II is the dominating redox intermedi-
ate (not shown), which ﬁts well with the k3/k4 ratios of
betanin (k3/k4 = 14) and indicaxanthin (k3/k4 = 3.6).
Typically for a good peroxidase substrate, the polaro-
graphically determined hydrogen peroxide consumption
was fast and depended strongly on the betalain concen-
tration (not shown), indicating that with both betalains
MPO can maintain a high H2O2 turnover. This clearlydemonstrates that neither these betalains nor their oxi-
dation products act as inhibitors of MPO under these
conditions. By contrast, the reactivity of betalains with
myeloperoxidase is comparable or even higher than that
of biological substrates like tyrosine [22], ascorbate [23],
indoles [20] or tryptamines [20], suggesting that there are
neither thermodynamic nor kinetic restrictions. Beta-
lamic acid derivatives can bind at the hydrophobic re-
gion at the entrance to the distal heme pocket [24] and
both standard reduction potentials of the enzymatic
couples, compound I/compound II (1.35 V) and com-
pound II/ferric MPO (0.97 V) [25], have to be signiﬁ-
cantly higher than those of both betalains.
Reaction between betanin and indicaxanthin with
hypochlorous acid
Both betalains are good peroxidase substrates and
are oxidized by the enzyme rather than inhibiting it.
Fig. 3. Reaction of compound I and compound II of myeloperoxidase (MPO) with indicaxanthin. Experiments were carried out in the sequential-
mixing stopped-ﬂow mode. (A) Pseudo-ﬁrst-order rate constants, kobs, for compound I reduction plotted against indicaxanthin concentrations. (B)
Time trace and single-exponential ﬁt of the reaction between 1 lM MPO compound I and 20 lM indicaxanthin, followed at 456 nm (absorbance
maximum of compound II). Conditions: 100 mM phosphate buﬀer, pH 7.0, and 25 C. (C) Pseudo-ﬁrst-order rate constants, kobs, for compound II
reduction plotted against indicaxanthin concentrations. (D) Time trace and single-exponential ﬁt of the reaction between 1 lM MPO compound II
and 50 lM betanin, followed at 456 nm. Conditions as in (B).
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rous acid scavengers, we investigated their reactivity
towards HOCl by using the conventional stopped-
ﬂow method. Figs. 4A and C show the spectral
changes of betanin and indicaxanthin oxidation med-
iated by HOCl. In case of betanin, the absorbance at
536 nm decreased (Fig. 4A) and following this reac-
tion in the stopped-ﬂow apparatus at 536 nm gave
monophasic time traces (Fig. 4B). From the plot of
the kobs values versus the hypochlorous acid concen-
tration (Fig. 4B) the apparent bimolecular rate con-
stant of this oxidation reaction was calculated to be
(1.8 ± 0.2) · 104 M1 s1 (pH 7.0 and 25 C) (inset
to Fig. 4B).
Upon oxidation of indicaxanthin by HOCl the max-
imum of absorbance at 483 nm decreased and a reaction
product with an absorbance maximum at 464 nm was
formed in a monophasic reaction (Figs. 4C and D).
The bimolecular rate constant of this oxidation reactionwas calculated to be (7.7 ± 0.1) · 104 M1 s1 at pH 7.0
and 25 C (inset to Fig. 4D).
The obtained reaction rates of hypochlorous acid,
which is the major strong oxidant generated in neutro-
phils, with betalains are about three orders of magnitude
smaller than those with methionine and cysteine [26,27],
but are comparable to those with other amino acids or
biological targets [27]. Thus, in principle, by virtue of
their redox properties and scavenging of hypochlorous
acid produced by myeloperoxidase during phagocytosis,
betalains could be eﬀective as anti-inﬂammatory
molecules.
Impact of betalains on the chlorination activity of MPO
Finally, we studied the inﬂuence of betalains on the
MPO-mediated chlorination reaction of monochloro-
dimedone (MCD). At pH 7.0, both a stimulating and
inhibitory eﬀect was observed depending on the betanin
Fig. 4. Oxidation of betanin and indicaxanthin by hypochlorous acid. Spectral changes upon reaction of 2 lM betanin (A) and 2 lM indicaxanthin
(B) (bold spectra) with 100 lM hypochlorous acid in 100 mM phosphate buﬀer, pH 7.0, and 25 C. (A) First spectrum was recorded 1.3 ms after
mixing, further spectra were selected 35, 68, 147, 378, and 943 ms, and 2.33 s (bold) after mixing. (B) First spectrum was recorded 1.3 ms after mixing,
further spectra were selected 17, 32, 47, 63, 78, 117, and 283 ms (bold) after mixing. (C) Typical time trace at 536 nm selected from (A). The inset
shows the pseudo-ﬁrst-order rate constants, kobs, plotted against the HOCl concentration. (D) Typical time trace at 482 nm selected from (B). The
inset shows the pseudo-ﬁrst-order rate constants, kobs, plotted against the HOCl concentration.
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(Fig. 5). At low micromolar concentrations of betalains,
the chlorination activity was stimulated (Figs. 5A and B)
in the beginning of the reaction, but ﬁnally MCD chlo-
rination stopped. In case of betanin, increasing the beta-
nin concentration up to 6 lM dramatically increased the
chlorination rate of MCD (Fig. 5A). Simultaneously,
the scavenging of HOCl became more evident with
increasing betalain concentration thereby shortening
the length of the halogenation phase and, ﬁnally, com-
pletely inhibited MCD chlorination. This eﬀect was even
more pronounced in the case of indicaxanthin (Fig. 5B),
which ﬁts well with the 4 times better HOCl scavenging
capacity of indicaxanthin compared with betanin. These
ﬁndings also demonstrate that both betalains have to be
better scavengers of HOCl than MCD (assay concentra-
tion of MCD is 100 lM), which is commonly used to
monitor the chlorination activity of MPO.It is well known that in the MPO/H2O2/chloride sys-
tem compound II, which is outside the halogenation cycle,
accumulates with time due to compound II formation
from compound I mediated by H2O2 [28]. In addition,
as it has been demonstrated above, compound I is eﬃ-
ciently reduced by both betalains. Since chloride, H2O2,
and both betalains are competitors for compound I, dif-
ferences in their concentrations can lead to diﬀerent pseu-
do-ﬁrst-order rate constants and as a consequence a
stimulatory or an inhibitory eﬀect on theHOCl formation
can be observed. The chloride concentration in theMCD
assay as well as in human blood is very high (100 mM),
and in the presence of betalains compound II is eﬃciently
reduced. As a consequence, in the presence of betalains
compound II does not accumulate and at low betalain
concentrations the chlorination activity of MPO is even
enhanced by regaining MPO from its compound II form
for the chlorination cycle. The bimolecular rate constants
Fig. 5. Eﬀect of betanin and indicaxanthin on the monochlorodimedone chlorination by the MPO/H2O2/chloride system at pH 7.0. Kinetics traces in
the absence (a) or in the presence (b–g) of betanin (A) or indicaxanthin (B). Indicaxanthin and betanin in the assay were 0.5 lM (b), 1.0 lM (c),
1.5 lM (d), 3.0 lM (e), and 6.0 lM (f).
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increasing concentrations of betalains, the HOCl scav-
enging eﬀect of both substances becomes evident and
the chlorination of MCD becomes inhibited.
At pH 5.0, no stimulating eﬀect of the MPO-mediated
MCD chlorination could be observed and the chlorina-
tion ofMCD decreased upon increasing the betalain con-
centration from 1.5 to 8 lM and, ﬁnally, was completely
inhibited (not shown). This ﬁts well with the known fact
that at decreasing pH compound II formation becomes
less important since the rate of the two-electron reduction
of compound I exceeds that of the H2O2-mediated com-
pound II formation [16]. Therefore, at pH 5.0 low beta-
lain concentrations may not be able to compete with
chloride for compound I reduction, but can still scavenge
HOCl and thus inhibit MCD chlorination.
Summing up, we have shown that betanin and indica-
xanthin are good electron donors for MPO compound I
and II. They interfere with the catalytic cycle of the en-
zyme and can enhance its chlorination activity at very
low concentrations and pH 7.0. This activity is, how-
ever, modulated by the ability of both betalains to scav-
enge HOCl. At pH 5.0, where there is maximum release
of HOCl by MPO [2] both betalains act as scavengers al-
ready at low micromolar concentrations. Betalains,
therefore, may deserve a better investigation as modula-
tors in all the inﬂammatory conditions in which HOCl
plays a key role. It may be interesting to mention that
recent studies in humans showed that these phytochemi-
cals are bioavailable [29].Acknowledgment
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